工作经历

时间	单位	职位
	上海市肺部肿瘤临床医学中心	主任
	上海市胸部肿瘤研究所	副所长

教育经历

时间	学校	专业	学位

荣誉及其他

序号	称号
1	国务院特殊津贴获得者

发表文献

序号	文献名称(点击文献题目即可查看内容)	发表刊物	发表日期
1	Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment	Clin Cancer Res	2017
2	Guideline for diagnosis and treatment of ALK positive non-small cell lung cancer in China	Zhonghua Bing Li Xue Za Zhi	2015
3	Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study	Jpn J Clin Oncol	2015
4	Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy	Clin Cancer Res	2015
5	A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer	J Thorac Oncol	2015
6	Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer	Eur J Cancer	2014
7	Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version)	Zhonghua Bing Li Xue Za Zhi	2014
8	Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial	Lancet Oncol	2013
9	Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial	Lancet Oncol	2013
10	Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer	Onco Targets Ther	2013